MPX Announces Acquisition of Remaining Interests in Massachusetts Companies

TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX”) (CSE: MPX; OTC: MPXEF) announced that on December 28, 2018, it had agreed to acquire certain minority interests in two Massachusetts entities associated with certain cultivation and production activities. The entities include IMT, LLC and Fall River Development Co. LLC, both limited liability companies domesticated in Massachusetts (“Sellers”). Through its wholly-owned subsidiary CGX Life Sciences Inc. of Nevada, MPX currently owns fifty-one percent (51.0%) of each entity, and today announces its agreement to acquire the remaining interests in an all-stock transaction.

Read More: MPX Announces Acquisition of Remaining Interests in Massachusetts Companies

Leave a Reply

";